Yuanxiang Lin Selected Research

Yuanxiang Lin Research Topics

Disease

9	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2023 - 01/2017
8	Neoplasms (Cancer) 05/2024 - 01/2019
6	Brain Injuries (Brain Injury) 01/2023 - 01/2017
5	Glioma (Gliomas) 07/2022 - 01/2019
4	Cerebral Hemorrhage 01/2024 - 01/2021
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 08/2018
3	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 01/2022
3	Hydrocephalus (Hydrocephaly) 06/2022 - 01/2021
2	Brain Edema (Cerebral Edema) 08/2023 - 01/2017
2	Neuroinflammatory Diseases 01/2023 - 01/2017
2	Aneurysm (Aneurysms) 06/2022 - 01/2021
2	Epilepsy (Aura) 10/2021 - 09/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2024
1	Inflammation (Inflammations) 01/2024
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2023
1	Edema (Dropsy) 08/2023
1	Dizziness (Lightheadedness) 05/2023
1	Traumatic Intracranial Hemorrhage 05/2023
1	Headache (Headaches) 05/2023
1	Pain (Aches) 03/2023
1	Postoperative Pain 03/2023
1	Chronic Subdural Hematoma 01/2023
1	Consciousness Disorders 01/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023
1	Intracranial Aneurysm (Cerebral Aneurysm) 06/2022
1	Rupture 06/2022
1	Brain Hypoxia (Cerebral Hypoxia) 06/2022
1	Infections 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Meningioma (Meningiomas) 01/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2020
1	Acromegaly 01/2020
1	Adenoma (Adenomas) 01/2020
1	Vascular Malformations 01/2019
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 06/2018
1	Necrosis 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Focal Cortical Dysplasia 09/2017
1	Drug Resistant Epilepsy 09/2017
1	Craniopharyngioma (Craniopharyngiomas) 01/2017

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2019
2	Neuroprotective AgentsIBA 01/2023 - 01/2017
2	Circular RNAIBA 07/2022 - 12/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2022 - 01/2021
2	Phosphates (Orthophosphate)IBA 06/2022 - 01/2021
2	Fibrinogen (Factor I)FDA Link 04/2020 - 01/2020
2	NeuroglobinIBA 01/2020 - 01/2018
1	IonophoresIBA 04/2024
1	IonsIBA 04/2024
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2024
1	IronIBA 08/2023
1	Phospholipases A2 (Phospholipase A2)IBA 01/2023
1	ferrostatin-1IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	EnzymesIBA 01/2022
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Histones (Histone)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Hydroxyl RadicalIBA 01/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 05/2021
1	Temozolomide (Temodar)FDA LinkGeneric 05/2021
1	Insulin (Novolin)FDA Link 01/2020
1	Growth Hormone (Somatotropin)IBA 01/2020
1	NFI Transcription FactorsIBA 12/2019
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2019
1	NAD (NADH)IBA 10/2019
1	CollagenIBA 01/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 08/2018
1	Sirolimus (Rapamycin)FDA Link 06/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	tat Gene Products (tat Protein)IBA 01/2018
1	Trans-Activators (Trans-Acting Factor)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2017
1	Nerve Growth Factor (NGF)IBA 09/2017
1	necrostatin-1IBA 01/2017

Therapy/Procedure

7	Therapeutics 04/2024 - 01/2017
3	Minimally Invasive Surgical Procedures 04/2023 - 01/2021
1	Craniotomy 05/2024
1	Conservative Treatment 05/2023
1	Aftercare (After-Treatment) 05/2023
1	Length of Stay 03/2023
1	Transplantation 01/2023
1	Local Anesthesia 01/2023
1	Immunotherapy 01/2022
1	Lasers (Laser) 01/2022
1	Treatment Delay 01/2021
1	Endoscopes 01/2019